Company intelligence
TriLink BioTechnologies, part of Maravai LifeSciences
About TriLink BioTechnologies, part of Maravai LifeSciences
TriLink BioTechnologies, a Maravai LifeSciences company, is a global leader in nucleic acid and mRNA solutions. TriLink delivers unrivaled chemical and biological experience, CDMO services, and high-quality readymade and custom materials, including its patented CleanCap® mRNA capping technology. Pharmaceutical leaders, biotech disruptors, and world governments depend on TriLink to meet their greatest challenges, from delivering the COVID-19 vaccine at warp speed, to empowering innovative treatments in oncology, infectious diseases, cardiology, and neurological disorders, to enabling future pandemic response plans. For more information, visit trilinkbiotech.com
Verified activity
Signals from TriLink BioTechnologies, part of Maravai LifeSciences
3 published signals
Products & Services
TriLink BioTechnologies, part of Maravai LifeSciences is exhibiting CleanCap capping technology and ModTail poly(A) tail modification chemistry.
Reported by TriLink BioTechnologies, part of Maravai LifeSciences
Presence & Recognition
TriLink BioTechnologies, part of Maravai LifeSciences is attending the 11th Annual CAR-TCR Summit Series in Boston.
Reported by TriLink BioTechnologies, part of Maravai LifeSciences
Presence & Recognition
TriLink BioTechnologies, part of Maravai LifeSciences, is building a new GMP enzyme manufacturing facility in Jupiter, Florida, featuring a two-hour facility tour and networking event on September 21.
Reported by Piyush Kapopara, B. Pharm, PhD